Elizabeth Papalardo - Concepedia

Concepedia

Author

Elizabeth Papalardo

The University of Texas Medical Branch at Galveston

Also Known As

E Papalardo, E. Papalardo, Elizabeth Papalardo, Papalardo, E

25

Publications

1.3K

Citations

14

H-Index

23

Concepts

All Affiliations

The University of Texas Medical Branch at Galveston Johns Hopkins University University of Alabama at Birmingham University of Puerto Rico, Medical Sciences Campus Instituto Politécnico Nacional

EP

About

Elizabeth Papalardo is an author at The University of Texas Medical Branch at Galveston specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	223
2	Immunology	3	3	223
3	Allergy	1	1	40
4	Pathology	1	1	56
5	Pharmacology	1	1	56

Elizabeth Papalardo

×

16

Publications

1.3K

Citations

14

H-Index

	Year	Citations
Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort Rohan Willis, A. M. Seif, Gerald McGwin, Lupus	2012	185
Markers of oxidative and nitrosative stress in systemic lupus erythematosus: Correlation with disease activity Gangduo Wang, Silvia S. Pierangeli, Elizabeth Papalardo, Arthritis & Rheumatism	2010	182
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo Zurina Romay‐Penabad, Maria Guadalupe Montiel-Manzano, Tuya Shilagard, Blood	2009	132
Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome Zurina Romay‐Penabad, Renan Aguilar‐Valenzuela, Rolf T. Urbanus, Blood	2010	127
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept Yiannis Ioannou, Z. Romay Penabad, Charis Pericleous, Journal of Thrombosis and Haemostasis Vivo InhibitionImmunologyAntiphospholipid Antibody-induced PathogenicityImmunodominancePeptide Therapeutic	2009	127
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients Doruk Erkan, Rohan Willis, Vijaya Murthy, Annals of the Rheumatic Diseases	2013	121
Value of Isolated IgA Anti–β<sub>2</sub>‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome Vijaya Murthy, Rohan Willis, Zurina Romay‐Penabad, Arthritis & Rheumatism	2013	106
C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies AL Carrera-Marín, Zurina Romay‐Penabad, Elizabeth Papalardo, Lupus	2012	63
Statins for the Treatment of Antiphospholipid Syndrome? Praveen Jajoria, Vijaya Murthy, Elizabeth Papalardo, Annals of the New York Academy of Sciences Vascular DiseaseImmunologyPathologyAntiphospholipid AntibodiesHyperlipidemia	2009	56
Evaluation of different immunoassays for the detection of antiphospholipid antibodies: Report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies Ricardo Forastiero, Elizabeth Papalardo, Michael Watkins, Clinica Chimica Acta Wet WorkshopImmunohematologyAllergyDifferent ImmunoassaysBioanalysis	2013	40

Page 1